SynthesisWiener klinische Wochenschrift2010
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.
Yuqin Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled ittrialcites it